Historically misunderstood to be rare and relatively benign, neuroendocrine tumors (NETs) are increasingly common and are now regarded as malignant neoplasms that can cause debilitating symptoms and potentially life-threatening issues for patients.1-5
Unlike lung cancer, which arises from the lung, or a breast cancer that arises from the breast, neuroendocrine tumors arise from a cell type. These neuroendocrine cells can really arise from [almost] anywhere in the body.
– Dr. Lowell Anthony
This shift in mindset is driving healthcare professionals and patient advocates to seek ways to make more timely and accurate diagnoses of NETs and emphasize the need for appropriate management strategies, including the importance of early treatment interventions.
In fact, the increasing incidence of NETs may be due, in part, to heightened awareness and improved diagnosis.6